Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service

Trinity Life Sciences Announces the Opening of State-of-the-art Office in India


Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the opening of its next-generation office space in Gurgaon, India. The opening of the new office is part of Trinity's ongoing commitment to support development and innovation in the Asia-Pacific region.

Located near the "cyber hub of India," the impressive new office boasts sleek contemporary design and state-of-the-art technology to support continued growth and global collaboration. Meeting rooms are equipped with a "one touch" video conferencing technology, and large agile breakout spaces are installed for employees to enjoy meeting together both informally and for business.

"It has been hugely rewarding to see the Gurgaon office grow from the small team at its inception in 2017 to the size it is now," said Yogesh Soneji, Senior Partner, Trinity Life Sciences. "The offerings that are provided by this office have fast become critical to the development of the global business, thanks to the regional team's innovative mindset and continued drive to exceed."

Despite the challenges of navigating a virtual working environment over the last two years, Trinity's Gurgaon office has more than doubled and is one of Trinity's fastest growing offices; a result of the supportive values-driven culture that has been fostered since the office was established.

"The Insights and Analytics Center of Excellence that we've built and continue to grow in India is integral to our industry-leading offerings. With this major presence in India, we can find unique talent to support and innovate for our clients who stand to benefit even more as this team expands," said Aparna Deshpande, Senior Partner, Insights.

Trinity's Strategic Operations team is also based in the Gurgaon office and empowers the Company with knowledge management, quality & delivery support and proposal management.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to solving clients' most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity's range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: